Regression of uveal malignant melanomas following cobalt-60 plaque. Correlates between acoustic spectrum analysis and tumor regression.
Parameters derived from computer analysis of digital radio-frequency (rf) ultrasound scan data of untreated uveal malignant melanomas were examined for correlations with tumor regression following cobalt-60 plaque. Parameters included tumor height, normalized power spectrum and acoustic tissue type (ATT). Acoustic tissue type was based upon discriminant analysis of tumor power spectra, with spectra of tumors of known pathology serving as a model. Results showed ATT to be correlated with tumor regression during the first 18 months following treatment. Tumors with ATT associated with spindle cell malignant melanoma showed over twice the percentage reduction in height as those with ATT associated with mixed/epithelioid melanomas. Pre-treatment height was only weakly correlated with regression. Additionally, significant spectral changes were observed following treatment. Ultrasonic spectrum analysis thus provides a noninvasive tool for classification, prediction and monitoring of tumor response to cobalt-60 plaque.
D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D006801:Humans; D008545:Melanoma / Q000145:classification / Q000473:pathology / Q000532:radiotherapy*; D013057:Spectrum Analysis; D014463:Ultrasonography; D014604:Uveal Neoplasms / Q000145:classification / Q000473:pathology / Q000532:radiotherapy*
D003037:Cobalt Radioisotopes